Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · Real-Time Price · USD
1.482
-0.038 (-2.48%)
Dec 3, 2024, 11:50 AM EST - Market open
Alterity Therapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for ATHE stock has a target of 4.00, which predicts an increase of 169.85% from the current stock price of 1.48.
Analyst Consensus: Buy
* Price targets were last updated on Mar 7, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for ATHE is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Buy Reiterates $4 | Buy | Reiterates | $4 | +169.85% | Mar 7, 2024 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Maintains $20 → $10 | Strong Buy | Maintains | $20 → $10 | +574.63% | Jun 5, 2023 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +1,249.25% | Aug 3, 2022 |
| Benchmark | Benchmark | Buy Initiates $40 | Buy | Initiates | $40 | +2,598.51% | Aug 20, 2021 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
No financial forecasts available for this stock
Revenue Forecast
No data available
Revenue Growth
No data available
EPS Forecast
No data available
EPS Growth
No data available
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.